20:46 , Feb 16, 2017 |  BC Innovations  |  Translation in Brief

Infecting cancer

Although adoptive T cell therapies have shown promising clinical efficacy for hematological malignancies, applying the strategy to solid tumors is more challenging because they form an immunosuppressive microenvironment. To overcome that suppression and boost antitumor...
07:00 , Jun 29, 2009 |  BC Week In Review  |  Company News

BloodCenter of Wisconsin sales and marketing update

BloodCenter launched its CEBPA Mutation Analysis genetic test for inherited acute myeloid leukemia (AML). The assay detects germline variants found within the coding and junctional regions of the CCAAT enhancer binding protein alpha (CEBPA) gene....